Literature DB >> 7905503

Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression.

S Sakaguchi1, T H Ermak, M Toda, L J Berg, W Ho, B Fazekas de St Groth, P A Peterson, N Sakaguchi, M M Davis.   

Abstract

Germline expression of rearranged TCR alpha-chain transgenes with the Ig H chain enhancer reproducibly elicits T cell-mediated autoimmune disease in the thyroid gland, gastric mucosa, Langerhans islets, salivary gland, ovaries, and testes in selected strains of normal mice. Multiple organs are destroyed in a single transgenic mouse and the same organ in transgenic strains with different MHC background, suggesting the transgene expression can elicit self-reactive T cell clones having different Ag specificities and MHC restrictions. Construction of this autoimmune-inducing TCR alpha EH transgene does not require particular V alpha J alpha gene segments or Ag specificities. Moreover, the autoimmune disease can be adoptively transferred to syngeneic normal mice by T cells expressing endogenous TCR alpha-chains. Taken together, these results indicate that the TCR alpha EH transgene expression does not suppress endogenous alpha-chain gene rearrangement and may trigger the expansion/activation of various self-reactive T cells expressing endogenous TCR alpha- and beta-chains. Furthermore, it appears that the transgene-induced autoimmune T cells are not deleted in the normal thymus or rendered anergic upon contact with the normal target self Ag, but can be controlled by a T cell-dependent mechanism, since transfer of the transgenic bone marrow cells to histocompatible SCID mice produces the same autoimmune disease as in the donors, and the autoimmune development in the SCID mice is effectively prevented by co-transfer of syngeneic nontransgenic T cells. This novel autoimmune model produced by genetic manipulation of the T cell lineage, not the target self Ag or the environment of T cell differentiation/selection, should be useful for elucidating the immunologic and genetic basis of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905503

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay.

Authors:  Simone Dunkelmann; Ricarda Wolf; Annedore Koch; Christian Kittner; Peter Groth; Carl Schuemichen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-19       Impact factor: 9.236

2.  Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells.

Authors:  M L Gumanovskaya; L K Myers; E F Rosloniec; J M Stuart; A H Kang
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

3.  Spontaneous autoimmune gastritis in C3H/He mice: a new mouse model for gastric autoimmunity.

Authors:  F Alderuccio; B H Toh
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

4.  Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease.

Authors:  Holly A Bolton; Erhua Zhu; Alexandra M Terry; Thomas V Guy; Woon-Puay Koh; Sioh-Yang Tan; Carl A Power; Patrick Bertolino; Katharina Lahl; Tim Sparwasser; Elena Shklovskaya; Barbara Fazekas de St Groth
Journal:  J Clin Invest       Date:  2015-08-24       Impact factor: 14.808

5.  A convenient model of severe, high incidence autoimmune gastritis caused by polyclonal effector T cells and without perturbation of regulatory T cells.

Authors:  Eric Tu; Desmond K Y Ang; Thea V Hogan; Simon Read; Cheryl P Z Chia; Paul A Gleeson; Ian R van Driel
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

6.  Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.

Authors:  M Asano; M Toda; N Sakaguchi; S Sakaguchi
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 7.  Lymphopenia and autoimmune diseases.

Authors:  Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2004-06-22       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.